These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2138127)

  • 1. Modulation of expression of the antigen identified by FMC7 upon human B-lymphocyte activation: evidence for differences between activation in vivo and in vitro.
    Ferro LM; Zola H
    Immunology; 1990 Mar; 69(3):373-8. PubMed ID: 2138127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
    Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
    Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pathway of human B cell activation initiated by CK226 surface antigen.
    Poggi A; Maggi E; Biagiotti R; Giudizi MG; Almerigogna F; Pella N; Caligaris-Cappio F; Romagnani S; Moretta L
    Eur J Immunol; 1990 May; 20(5):1161-5. PubMed ID: 2141569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
    Luo HY; Hofstetter H; Banchereau J; Delespesse G
    J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
    Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS
    J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.
    Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C
    Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin.
    Pezzutto A; Rabinovitch PS; Dörken B; Moldenhauer G; Clark EA
    J Immunol; 1988 Mar; 140(6):1791-5. PubMed ID: 3257985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody.
    Kikutani H; Nakamura H; Sato R; Kimura R; Yamasaki K; Hardy RR; Kishimoto T
    J Immunol; 1986 Jun; 136(11):4027-34. PubMed ID: 2422270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human interleukin 7 is a B cell growth factor for activated B cells.
    Joshi PC; Choi YS
    Eur J Immunol; 1991 Mar; 21(3):681-6. PubMed ID: 1826263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional properties of human B cell subpopulations defined by monoclonal antibodies HB4 and FMC7.
    Bloem AC; Chand MA; Dollekamp I; Rijkers GT
    J Immunol; 1988 Feb; 140(3):768-73. PubMed ID: 3257502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
    Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
    J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
    Yamashita T; Koyama J
    J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between IL-4, anti-CD40, and anti-immunoglobulin as activators of locomotion of human B cells.
    Komai-Koma M; Liew FY; Wilkinson PC
    J Immunol; 1995 Aug; 155(3):1110-6. PubMed ID: 7543514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the p27kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation.
    Blanchard DA; Affredou MT; Vazquez A
    J Immunol; 1997 Apr; 158(7):3054-61. PubMed ID: 9120257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of B lymphocytes via CD72 (human Lyb-2).
    Kamal M; Katira A; Gordon J
    Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
    Kehrl JH; Muraguchi A; Fauci AS
    J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
    Suzuki T; Cooper MD
    J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
    Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
    J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.